ASO Visual Abstract: Surgical Management and Outcomes in Pediatric Adrenocortical Carcinoma: A Pediatric Surgical Oncology Research Collaborative Study
Timestops (2)
Tools Used
Topic Overview
Key Takeaways
- Minimally invasive surgery was used in 17% of pediatric adrenocortical carcinoma cases and appears safe for select patients.
- Overall survival was significantly better in patients without metastatic disease at diagnosis.
- Multi-institutional data supports considering minimally invasive approaches in future pediatric ACC treatment guidelines.
- Stage at diagnosis was evenly distributed across the cohort, highlighting variable disease presentation.
- Surgical approach selection should be individualized based on metastatic burden and tumor characteristics.
Keywords
Hashtags
Transcript
Let's talk about pediatric adrenocortical carcinoma. I'm Jill Knepprath with Stay Current MD, and I want you to take a look at this abstract published in the Annals of Surgical Oncology. This was a multi-institutional study done by the Pediatric Surgical Oncology Research Collaborative. They looked at survival outcomes for kids with adrenal cortical carcinoma. Based on age, metastatic burden, and surgical approach, the stage of diagnosis was pretty evenly distributed. 17% of patients underwent a minimally invasive approach. Overall, survival was better for patients without metastases. The authors found that a minimally invasive approach can be a safe option for select patients, and they suggest considering it in future guidelines. What approach would you take?